Last reviewed: June 22, 2026
Last updated: June 22, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide therapy begins at a low dose and increases gradually to minimize side effects and optimize results. Most patients start between 0.25 mg and 0.5 mg weekly, with dose escalation occurring every 4 weeks based on individual response and tolerability. PlexusDx compounded semaglutide injections start at $149 per month, with doses adjusted by your dedicated provider team.
Standard Semaglutide Starting Dose Explained
The typical semaglutide starting dose is 0.25 mg injected subcutaneously once weekly. This low initial dose allows your body to adapt to GLP-1 receptor activation while your appetite regulation centers respond gradually. Clinical protocols recommend maintaining this dose for 4 weeks before any increase, giving your system time to establish tolerability and measure early weight loss responses.
Your starting dose depends on several individual factors beyond just body weight. Your prescribing provider evaluates your current metabolic status, any prior medication sensitivities, gastrointestinal health, and your personal weight loss goals. Some patients with sensitive systems benefit from starting at an even lower microdose, while others with higher baseline metabolic needs may progress more quickly through the titration schedule.
How Semaglutide Doses Increase Over Time
Most semaglutide protocols follow a 4-week titration schedule that moves from 0.25 mg to 0.5 mg, then 1.0 mg, and eventually to 2.4 mg maintenance doses. Each step occurs only after your body demonstrates good tolerability and you and your provider agree progression is appropriate. This gradual escalation strategy has reduced nausea and gastrointestinal side effects by up to 40% compared to faster titration schedules used in some clinical trials.
Your dose may need to go up—your price won't. PlexusDx structures semaglutide pricing at a flat monthly rate regardless of which dose level you're taking, removing financial barriers to finding your optimal therapeutic level. If your provider increases your dose in months 2, 3, or 4, your monthly investment remains the same, ensuring cost predictability throughout your treatment journey.
Factors That Influence Your Starting Semaglutide Dose
Your genetic makeup influences how your body responds to GLP-1 receptor stimulation and may predict your optimal starting dose. The GLP1R rs6923761 variant and related peptide-pathway genes affect receptor sensitivity and appetite suppression intensity. PlexusDx Precision Peptide Genetic Test identifies these 14 pathways and 49 peptides, helping providers personalize your starting dose based on your unique genetic predispositions rather than population averages.
Medical history shapes dose selection in important ways. Patients with type 2 diabetes, prior gastrointestinal surgery, or medications affecting digestion often start at the conservative 0.25 mg dose. Your age, kidney function, liver health, and any history of pancreatitis all inform whether your provider recommends standard or microdose initiation. PlexusDx providers review your complete health profile during your initial consultation to establish the safest, most effective starting point.
Getting Started With Semaglutide at PlexusDx
PlexusDx compounded semaglutide injections are prepared by licensed 503A compounding pharmacies and available in all 50 states without insurance requirements. Your PlexusDx plan includes provider consultation, ongoing dose adjustments, and pharmacy support—all starting at $149 per month for the first commitment tier. After your first month of treatment, you have the option to add the Precision Peptide Genetic Test for $99, unlocking personalized insights that may refine your current dose or guide future therapy optimization.
The enrollment process is straightforward: complete your health history, schedule a telehealth visit with a PlexusDx provider, receive your personalized treatment plan with starting dose recommendation, and arrange first delivery of your compounded medication. HSA and FSA accounts cover PlexusDx semaglutide therapy, making it accessible whether you carry traditional insurance or self-insure. Your dedicated provider team monitors your progress monthly, adjusts doses as needed, and ensures you're tracking toward your weight loss goals safely.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the lowest semaglutide starting dose available?
The standard lowest dose is 0.25 mg weekly, though PlexusDx offers a Microdose GLP-1 Protocol at $129/month for patients requiring gentler initiation. Your provider may recommend microdose if you have sensitive gastrointestinal systems or prior medication tolerability issues. This customized approach helps more patients remain on therapy without discontinuation due to early side effects.
How quickly does semaglutide dosing increase?
Standard protocols increase your dose every 4 weeks—moving from 0.25 mg to 0.5 mg to 1.0 mg and finally 2.4 mg. This gradual titration allows your body to adapt and minimizes gastrointestinal discomfort. Your PlexusDx provider may adjust this timeline based on your tolerability and response, potentially slowing progression if side effects emerge or accelerating if you're adjusting well and ready.
Does my semaglutide price change when my dose increases?
No. PlexusDx charges a flat monthly rate for compounded semaglutide injections starting at $149/month—your dose may need to go up, but your price won't. This pricing approach removes cost concerns about dose escalation, allowing you to focus on finding your therapeutic dose without financial penalties.
What side effects might occur at my starting dose?
Most patients experience mild nausea, appetite changes, or fatigue during the first 1-2 weeks at 0.25 mg, typically resolving by week 3 as your body acclimates. Constipation and reduced appetite are common as your GLP-1 pathways activate. Serious side effects like pancreatitis are rare; your PlexusDx provider screens for risk factors during initial consultation and monitors you throughout therapy.
Can genetic testing help determine my starting semaglutide dose?
Yes. PlexusDx Precision Peptide Genetic Test ($99 after your first month) analyzes peptide-pathway variants including GLP1R rs6923761, GIPR rs1800437, and others across 14 metabolic pathways. Patients with specific GLP1R variants may show enhanced receptor sensitivity, potentially benefiting from standard or gradual escalation protocols, while genetic patterns predict which patients need longer adaptation periods between dose increases.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Managing Digestive Comfort: Does Ozempic Help with GERD and Acid Reflux?
How Much Weight Can You Lose on Zepbound 5 mg?